# Palvella Therapeutics, Inc.: Form 8-K, filed Oct 28, 2026

- Company: [Palvella Therapeutics, Inc.](/companies/pvla.md) (CIK 1583648)
- Form: 8-K
- Filed: 2026-10-28
- Accepted by EDGAR: Oct 28, 2026, 07:30 ET
- Period: 2026-10-28
- Accession: 0001193125-26-435113
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1583648/000119312526435113/pvla-20261028.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1583648/000119312526435113/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1583648/000119312526435113/pvla-20261028.htm

Filed Oct 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-435113. Last ingested by Listed: Nov 13, 2026, 17:12 ET. No prices; not investment advice.